Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Genomic Testing Cooperative is a private cancer diagnostics company and clinical laboratory focused on comprehensive genomic profiling for oncology. The company provides DNA- and RNA-based next-generation sequencing assays for solid tumors, hematologic malignancies, and liquid biopsy samples, and markets these services through a cooperative model with laboratories, hospitals, and oncology practices. Its offerings emphasize integrated analysis of mutations, fusions, copy-number changes, gene expression, alternative splicing, clonality, and related biomarkers to support diagnosis, prognosis, therapy selection, and disease monitoring. GTC also develops AI-enabled interpretation software, including its web-based GTC Interpret platform built on the Interprestation suite, to help partner labs and clinicians analyze sequencing data and generate reports. The business is commercial-stage and operates as a precision oncology testing provider rather than a therapeutic drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Genomic Testing Collaborative.